Jibeier Pharmaceutical's director Hu Tao plans to reduce his holdings by no more than 1%

According to the Zhitong Finance APP, Jibeier Pharmaceutical announced that its shareholder holding more than 5%, Director Hu Tao plans to reduce his holdings by no more than 1.99 million shares through competitive trading or block trading, accounting for no more than 1% of the company's total share capital. The reduction period is from March 3, 2025, to May 30, 2025, and the reduction price will be determined at market price

According to the announcement from Jibeier Pharmaceutical (688566.SH), Hu Tao, a shareholder and director holding more than 5% of the company's shares, plans to reduce his holdings by no more than 1.99 million shares through competitive bidding or block trading, accounting for no more than 1% of the company's total share capital. The reduction period is from March 3, 2025, to May 30, 2025, with the reduction price determined by market price